⌘K

Home/Filings/4/0001209191-22-006020

4//SEC Filing

Dabora Rebecca 4

Accession 0001209191-22-006020

CIK 0001832038other

View on SEC.gov Company Profile

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 6:13 PM ET

Size

5.5 KB

Accession

0001209191-22-006020

Insider Transaction Report

Form 4

Period: 2022-01-30

Adagio Therapeutics, Inc.ADGI

Chief Technology Officer

Transactions

Award
Stock Option (Right to Buy)
2022-01-30+175,000→ 175,000 total
Exercise: $6.78Exp: 2032-01-29→ Common Stock (175,000 underlying)

Footnotes (1)

[F1]This option vests in equal monthly installments over a four-year period measured from one month following January 30, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Adagio Therapeutics, Inc.

CIK 0001832038

Entity typeother

Related Parties

1

filerCIK 0001875611

Filing Metadata

Form type: 4
Filed: Jan 31, 7:00 PM ET
Accepted: Feb 1, 6:13 PM ET
Size: 5.5 KB

View on SEC.gov